Clinical trial investigating the effects of median nerve stimulation on Tourette syndrome is now underway

    
October 20, 2022

The clinical trial investigating the effects of median nerve stimulation on Tourette syndrome and associated symptoms has completed recruitment and all participants are now in the ‘follow-up period’, in which participants health is monitored for 6 months.

The results from the trial will be published in 2023.

We thank everybody who showed interest in taking part in the trial and we thank Tourette’s Action for their help with recruitment and continuous support.

Company number: 13198315 

Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road
Nottingham 
England
NG7 2TU

Tourettes Friendly Organisation
All members of the Neurotherapeutics team have completed training with Tourettes Action educating them about Tourettes Syndrome, thus have been awarded with the Tourettes Friendly Organisation badge recognised by Tourettes Action.

Privacy Notice       Cookies

Neupulse and Neutrack are registered trade marks of Neurotherapeutics Ltd

Website by Clifton Media

Back to Top
crossmenu